Study of Onyda XR for ADHD and ODD in children
Part of Mental health clinical trials.
This trial tests a new extended-release medication called Onyda XR (clonidine) in children aged 6 to 12 who have both ADHD and Oppositional Defiant Disorder. The goal is to see if it helps with symptoms like inattention, hyperactivity, and defiant behavior, and if it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 and 12 years old.
- Your child must have both ADHD and Oppositional Defiant Disorder (ODD) diagnosed by a doctor.
- You and your child must be able to speak, read, and understand English.
- Your child must stop taking stimulant medications 7 days before starting the study and other non-stimulant ADHD meds 14 days before.
- Your child cannot have certain other serious mental health conditions like bipolar disorder, psychosis, autism, or severe anxiety.
- Your child cannot have a history of heart problems, seizures (except febrile seizures before age 5), or high or low blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares stimulant and non-stimulant ADHD medicines in kids who have not taken ADHD medication before. It also studies how these treatments affect brain “reward” processes, which may be linked to substance-use risk.
This study tests whether viloxazine extended-release can reduce ADHD symptoms in children ages 4–5. It also checks safety in preschool-age kids, including heart and nervous-system side effects.
This trial studies how ADHD stimulant medicine may change disruptive behaviors like aggression, tantrums, or refusing instructions. It may help clinicians understand whether stimulant dosing is supporting both ADHD symptoms and day-to-day behavior.
This trial tests if the medication Foquest can help treat ADHD symptoms in adults aged 65 and older. It aims to see if it's safe and effective for this age group.
This study tests if Jornay PM, a long-acting ADHD medication, helps control symptoms, focus, and emotions throughout the day and into the early evening in adults with ADHD. It is an open-label study, meaning everyone knows they are getting the medication, and then they are randomly assigned to different observation groups.
This trial tests whether the medication Dyanavel XR (a long-acting amphetamine) can help reduce fatigue in adults with ADHD. It is for people who have both ADHD and significant tiredness, and who are not currently taking stimulant ADHD drugs.
Hear when a new ADHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.